The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N03 | Antiepileptics | |
| 3 | N03A | Antiepileptics | |
| 4 | N03AG | Fatty acid derivatives | |
| 5 | N03AG01 | Valproic acid |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Route | Amount |
|---|---|
| ORAL - Oral | 1.5 g |
| PAREN - Parenteral | 1.5 g |
| RECTAL - Rectal | 1.5 g |
| Active Ingredient | Description | |
|---|---|---|
| Valproic acid |
Valproic acid is anti-convulsant. The most likely mode of action for valproate is potentiation of the inhibitory action of gamma amino butyric acid (GABA) through an action on the further synthesis or further metabolism of GABA. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| CONVULEX Gastro-resistant capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| DEPAKENE Oral solution | Health Products and Food Branch (CA) | MPI, CA: SPM | |
| DEPAKINE CHRONO Prolonged-release tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| EPILIM CHRONOSPHERE Modified release granules | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| EPILIM Powder and solvent for solution for injection / infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| EPIVAL Prolonged-release tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| RUBILIM Prolonged release tablet | Health Products Regulatory Authority (ZA) | MPI, Generic |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
